CERO THERAPEUTICS HOLDINGS, INC. Other Current Liabilities
CERO THERAPEUTICS HOLDINGS, INC. (CERO) had Other Current Liabilities of $692 as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Other Liabilities, Current $692.00.
- 2026-03-31: Other Liabilities, Current $692.00.
- 2025-12-31: Other Liabilities, Current $692.00.
- 2024-12-31: Other Liabilities, Current $692.00.
| Period end | Other Liabilities, Current |
|---|---|
| 2026-06-30 | $692.00 10-Q · filed 2026-08-14 |
| 2026-03-31 | $692.00 10-Q · filed 2026-05-15 |
| 2025-12-31 | $692.00 10-Q · filed 2026-08-14 |
| 2024-12-31 | $692.00 10-K · filed 2026-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |